Haemophilus parasuis is a porcine respiratory pathogen, well known as the aetiological agent of Glä sser's disease. H. parasuis comprises strains of different virulence, but the virulence factors of this bacterium are not well defined. A neuraminidase activity has been previously detected in H. parasuis, but the role of sialylation in the virulence of this bacterium has not been studied. To explore the relationship between sialic acid (Neu5Ac) and virulence, we assessed the distribution of genes involved in sialic acid metabolism in 21 H. parasuis strains from different clinical origins (including nasal and systemic isolates). The neuraminidase gene nanH, together with CMP-Neu5Ac synthetase and sialyltransferase genes neuA, siaB and lsgB, were included in the study. Neuraminidase activity was found to be common in H. parasuis isolates, and the nanH gene from 12 isolates was expressed in Escherichia coli and further characterized. Sequence analysis showed that the NanH predicted protein contained the motifs characteristic of the catalytic site of sialidases. While an association between the presence of nanH and the different origins of the strains was not detected, the lsgB gene was predominantly present in the systemic isolates, and was not amplified from any of the nasal isolates tested. Analysis of the lipooligosaccharide (LOS) from reference strains Nagasaki (virulent, lsgB + ) and SW114 (non-virulent, lsgB " ) showed the presence of sialic acid in the LOS from the Nagasaki strain, supporting the role of sialylation in the virulence of this bacterial pathogen. Further studies are needed to clarify the role of sialic acid in the pathogenicity of H. parasuis.
INTRODUCTION
Haemophilus parasuis is an NAD-dependent bacterium belonging to the family Pasteurellaceae. It is an early colonizer of the upper respiratory tract of healthy pigs and also the aetiological agent of Glässer's disease, a systemic disease characterized by polyarthritis, polyserositis and meningitis (Rapp-Gabrielson et al., 2006) . Strains of H. parasuis diverge in various aspects, including their virulence. H. parasuis is an important swine pathogen, but its virulence factors are poorly characterized. Lichtensteiger & Vimr (1997 , 2003 described a neuraminidase activity located in the outer membrane of H. parasuis. This location indicates a possible role of the protein as an antigen, but the specific role of the enzyme has not been determined. Sialic acid has been described as a virulence determinant in several bacterial species, including Streptococcus intermedius, Vibrio cholerae, Streptococcus pneumoniae and Haemophilus influenzae (Almagro-Moreno & Boyd, 2009; Jenkins et al., 2010; Marion et al., 2011; Takao et al., 2010) . Mechanistically, bacterial neuraminidases scavenge sialic acid (N-acetylneuraminic acid or Neu5Ac) from host glycoconjugates, which after internalization by specific transporters, can be used as a carbon and/or nitrogen source, or can be activated in a reaction catalysed by a CMP-Neu5Ac synthetase and used to sialylate surface molecules, commonly the lipooligosaccharide (LOS) (Steenbergen et al., 2005) . LOS sialylation is carried out by sialyltransferases. LOS sialylation is a molecular mimicking mechanism extensively used by bacteria to evade the host immune system. This molecular mimicry has been associated with an enhancement of bacterial resistance to serummediated killing in members of the family Pasteurellaceae (Hood et al., 1999; Inzana et al., 2002) . Besides a neuraminidase 3These authors contributed equally to this work. IP: 54.70.40.11
On: Wed, 24 Jul 2019 08:28:20 (or NanH), bacteria need a group of other enzymes to use sialic acid in catabolism or in LOS modification (Steenbergen et al., 2005) . A repertoire of genes encoding proteins involved in sialic acid utilization has been identified and characterized in several members of the family Pasteurellaceae. For example, H. influenzae is endowed with genes encoding enzymes necessary to modify LOS, including the CMP-Neu5Ac synthetase SiaB, and lipopolysaccharide sialyltransferases such as LsgB, Lic3A, Lic3B and SiaA (Fox et al., 2006; Hood et al., 2001; Jones et al., 2002) .
Little information is currently available regarding sialic acid utilization by H. parasuis and the distribution of genes encoding sialic acid-related functions. Based on gene sequence homology, a number of genes encoding putative sialic acid-related enzymes have been annotated in the genome of H. parasuis strain SH0165 (Xu et al., 2011) . In addition, Jin et al. (2008) reported the transcription of a siaB/neuA homologue during infection, suggesting a role for sialic acid in the pathogenesis of this bacterium. In this study, we analysed the presence of the genes nanH, siaB, neuA and lsgB in strains from different clinical origins and studied their association with virulence mechanisms already described for H. parasuis.
METHODS
Bacterial strains and plasmids. Two H. parasuis reference strains, SW114 (non-virulent) and Nagasaki (virulent), and 19 field strains, including both clinical and nasal isolates, were used. The main characteristics of the strains are presented in Table 1 . It may be noted that strains isolated from the nasal cavities of healthy animals from farms free of disease have been associated with being susceptible to serum and to macrophage phagocytosis, while strains from systemic lesions have been associated with resistance to serum and to macrophage phagocytosis (Cerdà-Cuéllar & Aragon, 2008; Olvera et al., 2009 ). In addition, by MLST, nasal strains cluster in a group different from systemic strains (Olvera et al., 2006) . All strains were stored in 20 % glycerol/brain heart infusion (BHI; Oxoid) at 280 uC, and were cultured on chocolate agar plates (bioMérieux) at 37 uC with 5 % CO 2 , or in PPLO or BHI broth supplemented with 10 mg NAD ml 21 at 37 uC with shaking.
Escherichia coli BL21 was grown at 37 uC in Luria-Bertani (LB) medium, supplemented with 30 mg chloramphenicol ml 21 when appropriate.
Neuraminidase activity. For preliminary determination of neuraminidase activity, a microtitre assay was performed, based on a published method (Potier et al., 1979; Lichtensteiger & Vimr, 1997) . Briefly, one to two colonies of each bacterial culture were resuspended in 25 ml of 110 mM 2-(4-methylumbelliferyl)-a-D-N-acetyl neuraminic acid (MUNAA) in 100 mM acetate buffer (pH 4.6) in 96-well plates. After 10 min of incubation at 37 uC in the dark, release of methylumbelliferone was observed under a UV transilluminator.
To quantify the neuraminidase activity using the above microtitre assay, 25 ml of broth cultures of each H. parasuis strain (OD 660 0.8) was mixed with 25 ml of 110 mM MUNAA in 100 mM acetate buffer (pH 4.6) in a 96-well plate. The reaction was incubated at 37 uC and the release of fluorescent methylumbelliferone was quantified (excitation 355 nm, emission 460 nm) after incubation at different times. Culture medium was used as a negative control.
PCR amplification, cloning and sequencing. Primers to amplify genes nanH (neuraminidase), neuA and siaB (CMP-NeuNAc synthetases), and lsgB (lipopolysaccharide sialyltransferase), from H. parasuis were designed using the genome sequence of strain SH0165 (GenBank accession no. NC_011852) ( Table 2) . PCRs were performed using 100 ng genomic DNA of each H. parasuis strain and 10 pmol of each primer pair (Table 2) in a final reaction volume of 25 ml. Amplification was performed with 35 cycles of 30 s at 94 uC, 45 s at 55 uC and 90 s at 72 uC, followed by 7 min at 72 uC for final elongation. PCR results were analysed by electrophoresis on 1 % agarose gels and ethidium bromide staining. For lsgB, a second pair of primers, located outside the ORF (77 bp upstream and 70 bp downstream) was used, with an annealing temperature of 50 uC.
For nanH, six amplicons from each group of strains (nasal and systemic) were purified and cloned into the SalI site of pACYC184. E. coli BL21 was used as a host for heterologous expression of the recombinant clones. Clones were checked for neuraminidase activity, as described above for H. parasuis, and were used to sequence the corresponding nanH genes (accession nos JN860075-JN860085). Sequencing reactions were performed with a BigDye Terminator v.3.1 kit and an ABI 3100 DNA sequencer (Applied Biosystems). Sequence editing and analysis were carried out using Fingerprinting II v3.0 software (Bio-Rad) and BLAST.
Serum and phagocytosis susceptibility assays. Bacterial resistance to serum-mediated killing and phagocytosis by porcine alveolar macrophages were determined as described previously (Cerdà-Cuéllar & Aragon, 2008; Olvera et al., 2009) . Data already available were completed by assaying strains IT29205, 9904108 and PV1-12 for serum resistance, and strains IQ1N-6, VS6-2, 9904108, FL1-3, 373/ 03A, PV1-12, 228/04 and IT29205 for phagocytosis resistance.
LOS purification and analysis. For LOS purification, Nagasaki and SW114 strains were grown in BHI medium supplemented with 10 mg NAD ml 21 and 25 mg sialic acid ml 21 . Proteinase K-digested whole-cell lysates were prepared as described earlier (Dubray & Limet, 1987; Garin-Bastuji et al., 1990) , with some modifications. Briefly, bacterial pellets from 300 ml of cultures were suspended in 0.0625 M Tris/HCl buffer (pH 6.8) containing 2 % SDS [1 g (wet weight) of cells per 20 ml]. Samples were heated at 100 uC for 10 min, and the lysates were tempered to 55 uC. Proteinase K was added at 0.15 mg ml 21 , and the samples were incubated at 55 uC for 3 h and then kept overnight at 20 uC. LOS was then precipitated by addition of four vols 2-propanol at 4 uC. The samples were stored at 220 uC for 1 h, and the precipitate was harvested by centrifugation at 5000 g for 30 min at 4 uC. Pellets were treated with RNase and DNase I (Boehringer), both at 0.01 mg ml 21 in 0.0625 M Tris/HCl buffer (pH 6.8), at 37 uC for 1 h. In order to eliminate both nucleases from the sample, an additional treatment with proteinase K was carried out at 12.5 mg ml 21 . After a second 2propanol precipitation and centrifugation, the pellets were dried and stored. LOS samples were analysed by the Tris/HCl-glycine buffer system described by Laemmli (1970) using 16620 cm gels with polyacrylamide concentrations of 4 and 18 % for the casting and running gels, respectively, and stained by the periodate-alkaline silver method (Tsai & Frasch, 1982) . LOS was also analysed after treatment with neuraminidase from Clostridium perfringens (Sigma-Aldrich) by using a concentration of 0.05 U per microgram of LOS in PBS at 37 uC for 4 h. These samples were treated with proteinase K, and after a final 2-propanol precipitation and centrifugation, pellets were dried and stored for analysis as described above.
RESULTS AND DISCUSSION
Detection of neuraminidase activity in H. parasuis strains
Twenty-one H. parasuis isolates including 10 nasal strains and 11 strains from lesions were tested for neuraminidase activity by measuring the level of reaction with the fluorescent substrate MUNAA. For clarity, Fig. 1(a) shows the results obtained for 11 of the H. parasuis strains. Five strains showed no neuraminidase activity (results for strains IT29205, FL1-3 and PV1-12 are not shown but were comparable with those of strains 2725 and F9; Fig.  1a ). The remaining 16 H. parasuis strains showed neuraminidase activity, with some diversity in terms of activity level among strains. The results for strains MU21-2, ER-6P, IQ1N-6, P015/96, 264/99, PC4-6P and SC14-1 (not shown) were similar to those obtained for strains Nagasaki, ND14-1, SW114 and 373/03A (Fig. 1a) . The low activity produced by strains SL3-2 and VS6-2 is noteworthy. Thus, different strains produced different quantities of enzyme, as observed by the diverse levels of reaction 
at the beginning of the incubation with MUNAA (t50). However, most strains displayed high fluorescence levels from the beginning of the reaction, which did not vary greatly through the experiment, suggesting that the reac-tion was saturated from the start of the assay. To confirm this observation, the assay was performed with bacterial cultures that were previously diluted. Fig. 1(b) shows the results obtained for strains Nagasaki and SW114, showing an exponential increase of neuraminidase activity, which indicates that the reaction with plain cultures was saturated. The same results were obtained when diluted cultures of strains ND14-1, CA38-4 and SC14-1 were used in the assay (not shown). The group of strains with the highest level of neuraminidase activity included strains of both nasal and systemic origin. No correlation between production of neuraminidase activity and the clinical origin of the strains was found, since 80 % of nasal strains and 73 % of systemic strains showed this activity. Together, these data suggest that the neuraminidase activity of H. parasuis detected with MUNAA is extensively distributed (76.1 % of screened isolates). Also, this activity may not be essential for virulence or nasal colonization, since we detected both nasal and clinical isolates that lacked this enzymic activity.
Amplification, sequencing and heterologous expression of nanH
Neuraminidase activity in H. parasuis is expected to be encoded by nanH (Xu et al., 2011) . To further study the differences observed in neuraminidase activity level among strains, the nanH gene was PCR-amplified from the 21 H. parasuis strains under study. The amplicon obtained, with a total size of approximately 2500 bp, contained the nanH gene and 79 bp upstream of the gene, in which a putative promoter region was detected with the BPROM program. The nanH gene was successfully amplified from all the strains; in two of them, strains 2725 and IT29205, the amplified products were bigger than those obtained for the rest of strains (~3800 bp versus 2500 bp).
The nanH amplicons from 12 strains (including both nasal and systemic isolates, as well as the virulent reference strain Nagasaki and the non-virulent reference strain SW114) were cloned into pACYC184 and introduced into E. coli BL21 to check the activity of the recombinant enzymes. The neuraminidase activity was maintained after expression in the heterologous host E. coli (Fig. 2) , but in all cases the level of activity detected was lower than in the original H. parasuis strains. This result suggests that accessory molecules, absent in E. coli, may be required for full activity of H. parasuis NanH.
Sequencing of the amplicons was performed in an attempt to detect differences related to the different level of activity observed among strains. Analysis of the putative promoter regions revealed few sequence differences amongst strains, which did not explain the differences in neuraminidase activity (not shown). Analysis of the gene sequences responsible for neuraminidase activity showed that the predicted protein contained the motifs characteristic of the catalytic site of sialidases and an Asp-box, indicating that H. parasuis neuraminidase has the essential residues for the enzymic activity under study (Fig. 3) .
When the 12 gene sequences were analysed, the reason for negative neuraminidase activity in three strains was discovered. For strain F9, a 2 nt insertion at position 651 of the gene was detected. This insertion changed the reading frame, which would generate a truncated protein of 222 aa (the first 217 aa corresponding to the NanH sequence). This truncated variant would only have two of the positions of the catalytic site (R80 and D105), and therefore would yield a protein without activity. For clinical isolates IT29205 and 2725, a 1.3 kb insertion was detected at position 1465 of the gene, which is likely to explain why these strains do not possess neuraminidase activity. Fragments of this insertion sequence were also found in the genome of H. parasuis SH0165, and showed Fig. 3 . Alignment of NanH sequences from the H. parasuis strains shown on the left. A reference sialidase, 1EUS, is also included. The residues forming the catalytic site are indicated with an asterisk (those identified by an NCBI conserved domains search) or a plus sign (those identified by protein alignment). Non-viral sialidases have Asp-box motifs (indicated with a hash symbol in the alignment), whose function is unknown. In strain 228/04, NanH residue R303, forming the catalytic site, was identified at position 298 (R298, highlighted in grey in the figure) by an NCBI conserved domains search. Values in brackets indicate number of amino acids between specified residues.
homology to transposases found in a variety of bacterial species, including Gallibacterium anatis (YP_004419118.1), E. coli (EFZ58425.1), Erwinia pyrifoliae (YP_002650187.1) and Enterobacter cloacae (YP_003940625.1). When the putative protein sequences were analysed, some amino acid changes were detected (Fig. 3) . The residue R303, included in the catalytic site of the Nagasaki strain NanH (Fig. 3) , was identified at position R298 in strain 228/04. Interestingly, we detected a change at this position in strain VS6-2 (R298G), which could explain the poor activity of the enzyme from this particular isolate (Fig. 1) . The amino acid substitutions R298G and M235I (conserved change, outside the catalytic site) were the only differences found between the putative NanH from strain ND14-1 (strain with high neuraminidase activity) and that from strain VS6-2 (poor neuraminidase activity). This observation highlights the potential importance of residue R298 for H. parasuis NanH activity.
Distribution of neuA, siaB and lsgB genes and correlation with bacterial virulence mechanisms
We further proceeded to evaluate the distribution of other genes involved in sialic acid metabolism among the H.
parasuis strains under study. A search of the available complete sequence of H. parasuis SH0165 was performed, and genes encoding enzymes with homology to NeuA or SiaB (72 and 77 % identities) and LsgB (34 % identity and a high expect value of 2e-93 in PSI-BLAST) were detected. While no correlation could be observed between the presence of neuA or siaB and the virulence of the strains, a clear correlation between the presence of lsgB (responsible for sialylation of LOS) and the virulence of the strains was observed; indeed, lsgB was only amplified from the clinical isolates and all nasal isolates tested were lsgB-negative (Table  3) . A second primer pair for lsgB amplification (lsgB-F2 and lsgB-R2), annealing outside the ORF, was used. Specific amplification with this second pair of primers was only detected in the strains giving positive amplification with primers lsgB-F1 and lsgB-R1 (not shown). Although these results infer a role for lsgB in the pathogenicity of H. parasuis, the gene may not be essential, since it was not detected in three clinical isolates. Alternatively, those strains could contain other sialyltransferase-encoding genes which would compensate the lack of lsgB in terms of LOS sialylation. These results also suggest that LOS sialylation may be an important factor in H. parasuis virulence. Next, we Table 3 summarizes the results of nanH, neuA, siaB and lsgB PCR amplification, and of serum and phagocytosis susceptibility. A good association between the presence of the necessary genes to sialylate LOS (nanH, siaB or neuA and lsgB) and serum resistance was observed (kappa5 0.788), while the association with phagocytosis resistance was weaker (kappa50.462). These results give strength to the hypothesis that LOS sialylation could confer an increased resistance to the bactericidal effect of sera and could be involved in modulating H. parasuis resistance to complement, as has been observed for H. influenzae (Hood et al., 1999; Martí-Lliteras et al., 2011; Nakamura et al., 2011) .
Analysis of LOS in H. parasuis
The structure of the H. parasuis LOS is currently unknown. LOS from the reference strains Nagasaki and SW114, grown in BHI medium supplemented with sialic acid, was examined by SDS-PAGE and periodate-alkaline silver staining, with and without neuraminidase treatment. LOS from the SW114 strain showed one band (Fig. 4, lane 1) , which was not affected by neuraminidase treatment (Fig. 4,  lane 2) . Conversely, LOS purified from the Nagasaki strain showed one band (Fig. 4, lane 3) , and neuraminidase treatment generated a second band with a slightly lower molecular mass (Fig. 4, lane 4) , suggesting the elimination of sialic acid from a fraction of the neuraminidase-treated LOS. These results suggest that, under the conditions tested, the virulent strain Nagasaki does sialylate its LOS molecule.
In conclusion, neuraminidase activity could be detected, quantified and correlated with the nanH gene sequence in the set of H. parasuis strains under analysis, although this activity did not display an apparent correlation with virulence. In contrast, the putative sialyltransferase-encoding gene lsgB was only detected in virulent strains, which also displayed a higher resistance to serum-mediated killing and phagocytosis by alveolar macrophages than nasal lsgB 2 strains. In addition, a correlation between the presence of lsgB and LOS sialylation could be established using two reference strains. These results warrant further study on the role of sialic acid in this bacterial pathogen.
Sialic acid mediated transcriptional modulation of a highly conserved sialometabolism gene cluster in Haemophilus influenzae and its effect on virulence. BMC Microbiol 10, 48. Fig. 4 . SDS-PAGE analysis of LOS purified from reference strains SW114 (lanes 1 and 2) and Nagasaki (lanes 3 and 4) grown in BHI supplemented with sialic acid. LOS preparations were treated with neuraminidase from C. perfringens (C. welchii) before electrophoresis (lanes 2 and 4) . The separating gel consisted of 18 % polyacrylamide and samples were stained with periodatealkaline silver.
